The applications of multiparameter flow cytometry are rapidly expanding due to the versatility of this technology and the depth of data that can be generated from a single sample. Continual ...
Researchers have developed a new methodology for the characterization of circulating leukemia cells, and other low-abundance cells, by flow cytometry. The technique enables quantification of ...
Prolongation of patients’ survival after the introduction of high-dose therapy (HDT) and novel agents into the up-front treatment of multiple myeloma (MM) is now unquestionable. 1 However, the ...
A recent study described the use of multiparameter flow cytometry to detect minimal residual disease, with an 8-color flow cytometric method with a 105 sensitivity, using monoclonal antibodies in ...
Technological change is often driven by the needs of people. Flow cytometry is no different. The designs of instruments and processing techniques are evolving to meet the needs of researchers and drug ...
Five hundred forty-two specimens of 150 children enrolled in the AML-Berlin-Frankfurt-Muenster (BFM) 98 study were analyzed by four-color immunophenotyping at up to four predefined time points during ...
Like A Determined Athlete, Flow Cytometry Is Training for More Demanding Routines Flow cytometry retains the ability to analyze thousands of particles per second. What’s more, flow cytometry shows no ...
In a large analysis presented at ASH's annual meeting, researchers reported that patients' MRD status after intensive chemo can predict their survival.
In the HARMONY Alliance Study of European randomized clinical trials, researchers sought to determine if MRD could serve as an intermediate endpoint in intensively treated AML.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback